HLA-ABC 抗体 (PE-Cy5)
Quick Overview for HLA-ABC 抗体 (PE-Cy5) (ABIN7673852)
抗原
See all HLA-ABC 抗体适用
宿主
克隆类型
标记
应用范围
克隆位点
-
-
原理
- PE-Cy5 Anti-Human HLA-A,B,C Antibody
-
纯化方法
- 0
-
纯度
- 0
-
亚型
- IgG2a, kappa
-
-
-
-
应用备注
- Volume per test: 5μL. Each lot of this antibody is quality control tested by flow cytometric analysis. The amount of the reagent is suggested to be used 5 μL of antibody per test (million cells in 100 μL staining volume or per 100 μL of whole blood). Please check your vial before the experiment. Since applications vary, the appropriate dilutions must be determined for individual use.
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
缓冲液
- PBS with 0. 1 % sodium azide, 1 % BSA, pH 7.3,
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
注意事项
- Avoid repeated freeze / thaw cycles.
-
储存条件
- 4 °C
-
储存方法
- 2-8°C for 12 months (Avoid repeated freeze / thaw cycles.)
-
有效期
- 12 months
-
-
- HLA-ABC
-
别名
- HLA-A,B,C
-
背景
-
Synonyms: MHC class I|Major Histocompatibility Class I
Background: MHC class I antigens associated with β2-microglobulin are expressed by all human nucleated cells. MHC class I molecules are involved in presentation of antigens to CD8+ T cells. They play an important role in cell-mediated immune responses and tumor surveillance.
-
分子量
- 0
-
基因ID
- 3105
-
UniProt
- P04439, P01889, P10321
-
途径
- TCR Signaling, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cancer Immune Checkpoints
抗原
-